U.S. RESEARCH ROUNDUP-Avid Bioservices, Equinix, Thermo Fisher Scientific

monday.com

24/06/2021 08:06

June 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Avid Bioservices, Equinix and Thermo Fisher
Scientific, on Thursday. 
    
    HIGHLIGHTS
    
     * Avid Bioservices Inc  CDMO.O : Stephens raises target price to $26 from $24
     * Equinix Inc  EQIX.O : Credit Suisse cuts target price to $907 from $932
     * Thermo Fisher Scientific Inc  TMO.N : Baird raises target price to $550 from $545
    
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday.
Stock entries are in alphabetical order. 
     
     * Avid Bioservices Inc  CDMO.O : Stephens raises target price to $26 from $24
     * Beauty Health Co  SKIN.O : Piper Sandler starts with overweight rating; $24 target price
     * Dish Network Corp  DISH.O : Credit Suisse raises target price to $45 from $34
     * Douglas Dynamics Inc  PLOW.N : Baird raises target price to $56 from $55
     * Enerpac Tool Group Corp  EPAC.N : RBC cuts target price to $26 from $27
     * Equinix Inc  EQIX.O : Cowen and Company raises target price to $890 from $790
     * Equinix Inc  EQIX.O : Credit Suisse cuts target price to $907 from $932
     * Equinix Inc  EQIX.O : JP Morgan raises target price to $895 from $861
     * Intellia Therapeutics Inc  NTLA.O : Baird raises target price to $85 from $60
     * KB Home  KBH.N : RBC raises target price to $47 from $46
     * Korn Ferry  KFY.N : Baird raises target price to $89 from $78
     * Monday.Com Ltd  MNDY.O : Berenberg initiates coverage with buy rating; target price $280
     * Thermo Fisher Scientific Inc  TMO.N : Baird raises target price to $550 from $545
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))